Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
OPL-053 by Overseas Pharmaceuticals for Insomnia: Likelihood of Approval
OPL-053 is under clinical development by Overseas Pharmaceuticals and currently in Phase I for Insomnia. According to GlobalData, Phase I...